Who is sponsoring NCT00817297?

NCT00817297 is sponsored by Respironics, California, Inc..

What drugs are being tested in NCT00817297?

Interventions in NCT00817297: noninvasive ventilator.

What condition does NCT00817297 study?

NCT00817297 studies Respiratory Insufficiency, Respiratory Failure.

Is NCT00817297 still recruiting?

NCT00817297 is currently completed. Last updated 17 November 2017.

Last reviewed 2017-11-17 · How we verify

NCT00817297

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

Completed NA Last updated 17 November 2017

What this trial tests

NA trial testing noninvasive ventilator in Respiratory Insufficiency in 16 participants. Completed in 7 April 2009.

Timeline

17 January 2009

Primary endpoint
3 March 2009

7 April 2009

Quick facts

Lead sponsor	Respironics, California, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	16
Start date	17 January 2009
Primary completion	3 March 2009
Estimated completion	7 April 2009
Sites	1 location across Canada

Drugs / interventions tested

noninvasive ventilator

Conditions studied

Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
Respiratory Failure — all drugs for Respiratory Failure →

Sponsor

Respironics, California, Inc.

Who can join

Adults 18 to 85, any sex, with Respiratory Insufficiency or Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare a new noninvasive ventilator to existing ventilators already used for patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Insufficiency

Currently open trials in the same condition.

NCT06653166 — Retrospective Data Analysis With the Aim to Determine the Success Rate of Endotracheal Intubation in the First Attempt i · active not recruiting
NCT06483984 — Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout · NA · recruiting
NCT05906030 — Diaphragm Dysfunction and Ultrasound Perioperatively · recruiting
NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
NCT06494215 — Comparison of Different Methods to Calculate Pendelluft by Electrical Impedance Tomography in Mechanically Ventilated Pa · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00817297 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Respironics, California, Inc.
Last refreshed: 17 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00817297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing